TSRO Insider Trading Activity and SEC Form 4 Filings
TSRO insider trading summary
No open-market insider purchases or sales of TESARO, Inc. (TSRO) have been reported on SEC Form 4 in the past 12 months.
Latest TSRO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 24, 2018 | Martin H. Huber Jr. | SVP & Chief Medical Officer | Sell | $14K (371 @ $37.63) |
| Sep 4, 2018 | Orlando Oliveira | SVP & GM, International | Sell | $2K (72 @ $32.44) |
| Aug 7, 2018 | Arnold L Oronsky | Director | Sell | $268K (10,000 @ $26.77) |
| Aug 1, 2018 | Joseph L Farmer | Sr VP, Gen Counsel & Secretary | Sell | $6K (187 @ $34.37) |
| Jun 12, 2018 | Lawrence M Alleva | Director | Sell | $125K (2,942 @ $42.62) |
| Jun 12, 2018 | Lawrence M Alleva | Director | Sell | $183K (4,200 @ $43.46) |
| Mar 8, 2018 | Orlando Oliveira | SVP & GM, International | Sell | $210K (3,000 @ $69.88) |
| Mar 6, 2018 | Peter J Barris | 10% Owner | Buy | $189K (3,159 @ $59.82) |
| Mar 6, 2018 | David M Mott | Director | Buy | $756K (12,634 @ $59.82) |
| Mar 6, 2018 | M James Barrett | 10% Owner | Buy | $756K (12,634 @ $59.82) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.